FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1

In their own right, the compounds investigated are less potent than desired for adjuvants in cancer chemotherapy, but the structures of the most potent inhibitors could serve as leads for the synthesis of more efficient adjuvants.